buyWeak
Julie Ann Shimer bought $9,925 of AVNS
director at AVANOS MEDICAL, INC.. 500 shares at an average of $19.85, traded Mar 11, 2024, filed Mar 11, 2024.
Conviction score
15Value
$9,925
500 shares
Holdings after
50,090
+1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- 0Trade size$10k at market
- 0Relative to holdingsHoldings up 1.0%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001606498-24-000043, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 11, 2024 | POpen-market purchase Common Stock | +500 | $19.85 | $9,925 | 50,090 | Mar 11, 2024 |
Related signals
Other insiders at AVANOS MEDICAL, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | AVNSsell AVANOS MEDICAL, INC. | Kerr Holbrook SVP, Chief Commercial Officer | $165k 15,000 shares | -15% | |
| 45Moderate | AVNSbuy AVANOS MEDICAL, INC. | Gary Blackford director | $659k 60,000 shares | +84% | |
| 25Weak | AVNSsell AVANOS MEDICAL, INC. | Kerr Holbrook SVP, Chief Commercial Officer | $107k 7,000 shares | -8% | |
| 33Weak | AVNSsell AVANOS MEDICAL, INC. | Michael Greiner SVP - Chief Financial Officer | $153k 8,000 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.